www.reuters.com/legal/litiga...
South Africa regulator reviews 12 generic semaglutide applications
South Africa's health regulator is reviewing 12 applications for generic versions of semaglutide, the active ingredient in Novo Nordisk's blockbuster diabetes and weight-loss medicines, it said on T...
reuters.com